TSC-203-A0201 is TScan’s fourth TCR-T cell product cleared for use in its solid tumor program, designed to enable customized, multiplexed TCR-T cell therapy WALTHAM, Mass., Aug. 29, 2023 (GLOBE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback